Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lara Kremer"'
Autor:
Tim Nestler, Lara Kremer, Melanie von Brandenstein, Maike Wittersheim, Pia Paffenholz, Svenja Wagener‐Ryczek, Alexander Quaas, Martin Hellmich, Stefan Müller, David Pfister, Margarete Odenthal, Axel Heidenreich
Publikováno v:
Cancer. 129:634-642
Before postchemotherapy retroperitoneal lymph node dissection (pcRPLND), in patients with metastasized germ cell tumors (GCTs), those harboring necrosis (NEC) cannot be distinguished from those who have teratoma (TER), resulting in relevant overtreat
Autor:
Tim Nestler, Lara Kremer, Melanie Von Brandenstein, Maike Wittersheim, Svenja Wagener-Ryczek, Pia Paffenholz, Stefan Mueller, Alexander Quaas, Martin Hellmich, Margarete Odenthal, David Pfister, Axel Heidenreich
Publikováno v:
Journal of Urology. 209
Autor:
Lara Kremer, Martin Hellmich, Barbara Koeditz, Tim Nestler, David G. Pfister, Maike Wittersheim, Axel Heidenreich, Pia Paffenholz, Melanie von Brandenstein
Publikováno v:
Journal of Urology. 206
Autor:
Axel Heidenreich, Tim Nestler, David Pfister, Maike Wittersheim, Lara Kremer, Pia Paffenholz, Melanie von Brandenstein, Martin Hellmich, Barbara Koeditz
Publikováno v:
Transl Androl Urol
BACKGROUND: To identify a combination of microRNAs (miRNA) to differentiate between viable tumor (V) or teratoma (T) and necrosis/fibrosis (N) in pcRPLND specimens of metastatic germ cell tumor (GCT) patients with residual masses ≥1 cm after chemot
Autor:
Tim Nestler, Lara Kremer, Melanie von Brandenstein, Barbara Koeditz, Pia Paffenholz, Martin Hellmich, David Pfister, Axel Heidenreich
Publikováno v:
Journal of Clinical Oncology. 40:421-421
421 Background: Our objective was to identify a combination of microRNAs (miRNA) to differentiate between viable tumor (V) or teratoma (T) and necrosis/fibrosis (N) in pcRPLND specimens of metastatic nonseminomatous germ cell tumor (NSGCT) patients w